StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

CASI Pharmaceuticals's total debt was $19.19M at Dec 31, 2025. For fiscal 2025 it was $19.19M, up 4.4% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$19.19M+4.4%
FY2024Dec 31, 2024$18.39M-2.7%
FY2023Dec 31, 2023$18.90M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$19.19M–
Q4 FY2024Dec 31, 2024$18.39M–
Q4 FY2023Dec 31, 2023$18.90M–

More CASI Pharmaceuticals figures

See a number that looks wrong?